Statements of Cash Flows - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ (3,000)	$ 1,437,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest income in Trust Account		(39,000)
Warrant liability issuance costs		639,000
Charge associated with issuance of private placement warrants		832,000
Change in fair value of warrant liability		(12,292,000)
Changes in operating assets and liabilities:
Increase in accounts payable		29,000
Increase in accrued liabilities		6,846,000
Increase in deferred compensation		383,000
Increase in accrued income and franchise taxes and rounding		200,000
Net cash used in operating activities	(3,000)	(1,965,000)
Cash flows from investing activities:
Cash deposited in Trust Account		(345,000,000)
Net cash used in investing activities		(345,000,000)
Cash flows from financing activities:
Proceeds from sale of Class B common stock to Sponsor	25,000
Proceeds from note payable to Sponsor	150,000
Proceeds from sale of Units to the public		345,000,000
Proceeds from sale of Private Placement Warrants		10,400,000
Payment of underwriting discounts		(6,900,000)
Payment of offering costs	(100,000)	(544,000)
Payment of Note payable to Sponsor		(150,000)
Net cash provided by financing activities	75,000	347,806,000
Net increase (decrease) in cash	72,000	841,000
Cash at beginning of period		72,000
Cash at end of period	72,000	913,000
Supplemental disclosure of non-cash financing activities:
Deferred offering costs included in accounts payable and accrued liabilities	$ 79,000
Offering costs included in accounts payable		70,000
Deferred underwriters’ compensation		$ 12,075,000